MedPage Today on MSN
Thrombolysis No Better Than Aspirin for Central Retinal Artery Occlusion
Vision recovery similar at 30 days, consistent with other recent randomized studies ...
Vascular Access Device Market OverviewThe global vascular access device market is witnessing consistent growth and is ...
Manual therapy — joint mobilization and soft-tissue techniques—adds critical short-term benefits. Studies demonstrate that ...
This is 40-something. Kim Kardashian, 45, has tried to cling to her youth by undergoing skin-tightening treatments, traveling ...
GlobalData on MSN
FDA to review Eisai’s Leqembi Iqlik sBLA for Alzheimer’s
The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.
Gwyneth Paltrow, 53, touted a popular longevity ingredient, beloved among tech bros and fitness influencers, as her latest ...
EDMONTON, ALBERTA, CANADA, January 14, 2026 / EINPresswire.com / — CareMed Wellness Clinic announces the launch of a nurse-led, tiered community care model designed to support individuals across ...
Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American ...
Sometimes, you don’t need to think about your brain. It just… runs. You wake up, remember your passwords (mostly), answer ...
Carrot and orange juice is rich in antioxidant and health boosting compounds. There are many health benefits to incorporating ...
The GINECO window-of-opportunity COLIBRI (NCT04256213) study provides compelling evidence that a neoadjuvant "priming" dose ...
Investigators compared the efficacy and safety of suvemcitug plus chemotherapy vs chemotherapy plus placebo for patients with platinum-refractory or resistant ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results